Verition Fund Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,218
Closed -$239K 2889
2021
Q3
$239K Buy
12,218
+7,032
+136% +$267K ﹤0.01% 1552
2021
Q2
$232K Buy
+5,186
New +$240K ﹤0.01% 1488

Other funds holding CELL

Verition Fund Management's CELL Position: Q4 2021 in Review

Verition Fund Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 12,218 shares — an estimated $239K sold.

Verition Fund Management first reported a position in CELL in Q2 2021 and held it in 2 quarters. The position peaked at $239K in Q3 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.

  • Verition Fund Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Verition Fund Management sold 12,218 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $239K.
  • Verition Fund Management first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Verition Fund Management's PhenomeX Inc. Common Stock position peaked at $239K in Q3 2021.
  • 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.

Based on Verition Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.